R
RainTree Oncology Services
RainTree Oncology Services
About RainTree Oncology Services
RainTree Oncology Services operates as a national group purchasing organization (GPO) and alliance for community oncology practices across the United States. The company was founded in 2011 by Dr. Jeffrey Patton, who served as its Chief Medical Officer, alongside other executives who had previously been with AmerisourceBergen's ION group. Dr. Patton, a board-certified hematologist and oncologist with extensive experience in clinical trial research, also held the role of CEO at Tennessee Oncology for a decade, bringing a deep, physician-led perspective to RainTree's mission of supporting community-based cancer care.
Read full description
The firm's business model is centered on empowering independent oncology practices to remain competitive and efficient. It achieves this by negotiating favorable purchasing contracts for pharmaceuticals, particularly oral oncolytics, and other necessary supplies, thereby leveraging the collective buying power of its members. RainTree also provides a suite of technology and support services to its member clinics. These include practice management tools, data analytics platforms to evaluate care pathways, and inventory management systems. This integrated approach helps practices improve operational efficiency, manage costs, and enhance patient care. A key component of its offering is assisting practices in establishing and operating on-site pharmacies, which provides patients with convenient access to medications and creates a new revenue stream for the practices.
RainTree serves community oncology practices, which are responsible for treating the majority of cancer patients in the U.S. The company's revenue is generated through the administration of GPO contracts and by providing its suite of management, technology, and pharmacy services to its network of members. Over the years, RainTree established significant partnerships, including collaborations with Express Scripts to launch a pharmacy network and with Cardinal Health, which became its exclusive distributor and GPO administrator for specialty medications in 2015 before acquiring the company in March 2016. The acquisition was a strategic move by Cardinal Health to expand its specialty distribution footprint, particularly in the growing oral oncology market.
At a glance
- Status
- Acquired
- Founded
- 2011
- Headquarters
- San Diego, United States
- Open positions
- None listed
- Dealroom signal
- 24.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Supply Chain Management, Risk Management, Retail, Biotechnology, Oncology, Patient Care, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning RainTree Oncology Services.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Mar 2016 | $0 | — | Cardinal Health | — |
| LATE VC✓Equity / VC | Aug 2012 | $23M | $91M | Undisclosed | — |
Growth signals
Latest recorded traffic for RainTree Oncology Services is 320 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors1 additional known investor
Cardinal Health
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about RainTree Oncology Services on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See RainTree Oncology Services’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







